Microsoft Word - 106937148_19 - Centocor - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2014-05-29 15:29:36 Pharmaceutical industry Biotechnology Food and Drug Administration Monoclonal antibodies Biosimilar Biologic Declaratory judgment Centocor Infliximab Pharmacology Pharmaceutical sciences Medicine		Microsoft Word - 106937148_19 Add to Reading List Source URL: orangebookblog.typepad.com Download Document from Source Website File Size: 159,46 KB Share Document on Facebook

	Ixekizumab for moderate to severe chronic plaque psoriasis DocID: 1gyoS - View Document
	438150This information is intended for UK medical media only 00This information is intended for UK medical media only MEDIA RELEASE • MEDIA RELEASE • MEDIA RELEASE CosentyxTM (secukinumab),▼the first IL- DocID: 1fNC6 - View Document
	Janssen Pharmaceutical Companies Product Due Date Status Description of Commitment or Requirement DocID: 1a6Du - View Document
	Infliximab (Remicade®) and Pregnancy In every pregnancy, a woman starts out with a 3-5% chance of having a baby with a birth defect. This is called her background risk. This sheet talks about whether exposure to inflixi DocID: 1a5mb - View Document
	Microsoft Word - 106937148_19 DocID: 19ODp - View Document